Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Nourish Revenue	-	5.87B	Log In	Log In	Log In	Upgrade
Health & Biosciences Revenue	2.25B	2.21B	Log In	Log In	Log In	Upgrade
Scent Revenue	2.45B	2.44B	Log In	Log In	Log In	Upgrade
Pharma Solutions Revenue	-	961.00M	Log In	Log In	Log In	Upgrade
Revenue (Other)	6.38B	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	11.07B	11.48B	Log In	Log In	Log In	Upgrade

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Nourish Adjusted Operating EBITDA	-	824.00M	Log In	Log In	Log In	Upgrade
Health & Biosciences Adjusted Operating EBITDA	596.00M	654.00M	Log In	Log In	Log In	Upgrade
Scent Adjusted Operating EBITDA	506.00M	518.00M	Log In	Log In	Log In	Upgrade
Pharma Solutions Adjusted Operating EBITDA	-	209.00M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-1.45B	-1.45B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-351.00M	755.00M	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2020
Nourish Capital Expenditures	235.00M	Log In	Log In	Log In	Upgrade
Health & Biosciences Capital Expenditures	73.00M	Log In	Log In	Log In	Upgrade
Scent Capital Expenditures	70.00M	Log In	Log In	Log In	Upgrade
Pharma Solutions Capital Expenditures	85.00M	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.